User banner image
User avatar
  • admin

Posts

OLAPLEX Reports Second Quarter 2024 Results

Reiterates Fiscal Year 2024 Guidance NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) — Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or the “Company”) today announced financial...

Body Firming Creams Market Outlook 2024-2030: Non Plant-based Creams Will Account for the Highest Total Revenue, but Plant-based Creams Expected to Register the Highest Growth

Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) — The “Body Firming Creams – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global...

[Latest] Global Medical Aesthetics Market Size/Share Worth USD 36,168.8 Million by 2033 at a 8.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Medical Aesthetics Market size &...

The 2024 Torch Festival in Liangshan Yi Autonomous Prefecture and Cultural Tourism Series are in Full Swing

LIANGSHAN, China, Aug. 06, 2024 (GLOBE NEWSWIRE) — Recently, the month-long 2024 Torch Festival in Liangshan Yi Autonomous Prefecture and the “Colorful Liangshan-Summertime Coolness” cultural and tourism...

TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

Patient enrollment has accelerated, now with 13 patients enrolled in trial TFF TAC at ~20% of the oral tacrolimus dose prevented acute rejection and achieved...

Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024

CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of...

Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist

MALVERN, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform...

Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC

19,000-square-foot facility reflects the company’s recent growth and continued commitment to the region MORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) — Science 37, a leader...

Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

Clinical update presented at ASCO 2024 for CRB-701 showed continued differentiated safety and encouraging efficacy in patients with metastatic urothelial cancer or cervical cancer CRB-701...

CoinEx Charity: Assisting the Venezuelan Region in Response to Hurricane Beryl’s Disasters

HONG KONG, Aug. 6, 2024 /PRNewswire/ — Recently, Hurricane Beryl, a Category 4 storm, wreaked havoc in the southeastern Caribbean, bringing intense winds and heavy...